Development of physiologically based pharmacokinetic and physiologically based pharmacodymamic models for applications in toxicology and risk assessment, Toxicology Letters, vol.79, issue.1-3, pp.35-44, 1995. ,
DOI : 10.1016/0378-4274(95)03355-O
An introduction to the use of physiologically based pharmacokinetic models in risk assessment, Statistical Methods in Medical Research, vol.91, issue.4, pp.341-58, 1997. ,
DOI : 10.1177/096228029700600404
Clinical Pharmacokinetics: Concepts and Applications, 1989. ,
Physiologically Based Pharmacokinetic Modeling: Principles and Applications, Journal of Pharmaceutical Sciences, vol.72, issue.10, pp.1103-1130, 1983. ,
DOI : 10.1002/jps.2600721003
Review Physiological pharmacokinetic modelling, Xenobiotica, vol.18, issue.11, pp.1241-57, 1990. ,
DOI : 10.3109/03602538409033558
A Bayesian compartmental model for the evaluation of 1,3-butadiene metabolism, Journal of the Royal Statistical Society: Series C (Applied Statistics), vol.50, issue.3, pp.291-305, 2003. ,
DOI : 10.1016/S0009-2797(01)00180-6
URL : https://hal.archives-ouvertes.fr/ineris-00962856
Species differences in the production and clearance of 1,3-butadiene metabolites: a mechanistic model indicates predominantly physiological, not biochemical, control, Carcinogenesis, vol.14, issue.4, pp.619-647, 1993. ,
DOI : 10.1093/carcin/14.4.619
Effects of the structure of a toxicokinetic model of butadiene inhalation exposure on computed production of carcinogenic intermediates, Toxicology, vol.113, issue.1-3, pp.31-40, 1996. ,
DOI : 10.1016/0300-483X(96)03424-5
Modélisation toxicocinétique de la concentration de 2,3,7,8-tetrachloro-p-dioxine après ingestion chez la femme, Environnement, Risques et Santé, vol.2, 2003. ,
Monte Carlo Methods, 1964. ,
Physiological parameters in laboratory animals and humans, Pharmaceutical Research, vol.10, issue.7, pp.1093-1098, 1993. ,
DOI : 10.1023/A:1018943613122
Physiological Parameter Values for Physiologically Based Pharmacokinetic Models, Toxicology and Industrial Health, vol.191, issue.1, pp.407-84, 1997. ,
DOI : 10.1177/074823379701300401
Reference Physiological Parameters in Pharmacokinetics modeling, 1988. ,
On the Dangers of Adjusting the Parameter Values of Mechanism-Based Mathematical Models, Journal of Theoretical Biology, vol.183, issue.4, pp.417-444, 1996. ,
DOI : 10.1006/jtbi.1996.0232
Sensitivity Analysis, Monte Carlo Risk Analysis, and Bayesian Uncertainty Assessment, Risk Analysis, vol.21, issue.4, pp.579-83, 2001. ,
DOI : 10.1111/0272-4332.214136
Proposed Occupational Exposure Limits for Select Ethylene Glycol Ethers Using PBPK Models and Monte Carlo Simulations, Toxicological Sciences, vol.62, issue.1, pp.124-163, 2001. ,
DOI : 10.1093/toxsci/62.1.124
Population toxicokinetics of benzene, Environmental Health Perspectives, vol.104, issue.Suppl 6, pp.1405-1416, 1996. ,
DOI : 10.1289/ehp.961041405
Physiological Pharmacokinetic Analysis Using Population Modeling and Informative Prior Distributions, Journal of the American Statistical Association, vol.55, issue.436, pp.1400-1412, 1996. ,
DOI : 10.2307/2533402
URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.44.2288
Bayesian Theory, 1994. ,
DOI : 10.1002/9780470316870
Markov Chain Monte Carlo in Practice, 1996. ,
Bayesian Data Analysis, 1995. ,
MCSim: a simulation program, Journal of Statistical Software, vol.2, issue.9, 1997. ,
Assessing, Accommodating, and Interpreting the Influences of Heterogeneity, Environmental Health Perspectives, vol.90, pp.215-237, 1991. ,
DOI : 10.2307/3430871
Pharmacokinetics, pharmacodynamics, and prediction of developmental abnormalities, Reproductive Toxicology, vol.11, issue.2-3, pp.413-419, 1997. ,
DOI : 10.1016/S0890-6238(96)00155-4
Statistical methods for population pharmacokinetic modelling, Statistical Methods in Medical Research, vol.7, issue.1, pp.63-84, 1998. ,
DOI : 10.1191/096228098670696372
Bayesian Individualization of Pharmacokinetics: Simple Implementation and Comparison with Non-Bayesian Methods, Journal of Pharmaceutical Sciences, vol.71, issue.12, pp.1344-1352, 1982. ,
DOI : 10.1002/jps.2600711209
The Bayesian Modeling of Covariates for Population Pharmacokinetic Models, Journal of the American Statistical Association, vol.43, issue.435, pp.917-944, 1996. ,
DOI : 10.2307/2986121
A pharmacokinetic analysis of interspecies extrapolation in dioxin risk assessment, Chemosphere, vol.35, issue.3, pp.427-52, 1997. ,
DOI : 10.1016/S0045-6535(97)00108-2
Extrapolation of a PBPK Model for Dioxins across Dosage Regimen, Gender, Strain, and Species, Toxicological Sciences, vol.56, issue.1, pp.49-60, 2000. ,
DOI : 10.1093/toxsci/56.1.49
Interspecies scaling and comparisons in drug development and toxicokinetics, Xenobiotica, vol.75, issue.11, pp.1201-1232, 1990. ,
DOI : 10.3109/03602538409033558
Interspecies Extrapolation of Physiological Pharmacokinetic Parameter Distributions, Risk Analysis, vol.75, issue.6, pp.741-54, 1996. ,
DOI : 10.1016/0378-4274(93)90103-5
Biological basis for extrapolation across mammalian species, Regulatory Toxicology and Pharmacology, vol.6, issue.3, pp.211-248, 1986. ,
DOI : 10.1016/0273-2300(86)90014-0
A Generic Toxicokinetic Model for Persistent Lipophilic Compounds in Humans: An Application to TCDD, Toxicological Sciences, vol.31, issue.1, pp.83-94, 1996. ,
DOI : 10.1093/toxsci/31.1.83
A computer model and program for xenobiotic disposition during pregnancy, Computer Methods and Programs in Biomedicine, vol.53, issue.3, pp.201-225, 1997. ,
DOI : 10.1016/S0169-2607(97)00020-5
Evaluation of methods for estimating population pharmacokinetic parameters -I ,
Population Models, Statistical Methodology in the Pharmaceutical Sciences, pp.139-62, 1990. ,
DOI : 10.1201/b16950-6
Population pharmacokinetics, International Journal of Clinical Pharmacology, Therapy, and Toxicology, vol.30, pp.520-522, 1992. ,
Population toxicokinetics of tetrachloroethylene, Archives of Toxicology, vol.70, issue.6, pp.347-55, 1996. ,
DOI : 10.1007/s002040050284
URL : https://hal.archives-ouvertes.fr/ineris-00969532
Nonparametric density estimation applied to population pharmacokinetics, Mathematical Biosciences, vol.133, issue.1, pp.51-68, 1996. ,
DOI : 10.1016/0025-5564(95)00079-8
Bayesian nonparametric population models: formulation and comparison with likelihood approaches, Journal of Pharmacokinetics and Biopharmaceutics, vol.25, issue.2, pp.235-53, 1997. ,
DOI : 10.1023/A:1025736230707
Optimal design for a study of butadiene toxicokinetics in humans, Toxicological Sciences, vol.49, issue.2, pp.213-237, 1999. ,
DOI : 10.1093/toxsci/49.2.213
URL : https://hal.archives-ouvertes.fr/ineris-00962757